Nutex Health Management

Management criteria checks 2/4

Nutex Health's CEO is Tom Vo, appointed in Apr 2022, has a tenure of 2.58 years. total yearly compensation is $1.01M, comprised of 98.6% salary and 1.4% bonuses, including company stock and options. directly owns 33.64% of the company’s shares, worth $52.63M. The average tenure of the management team and the board of directors is 2.6 years and 2.6 years respectively.

Key information

Tom Vo

Chief executive officer

US$1.0m

Total compensation

CEO salary percentage98.6%
CEO tenure2.6yrs
CEO ownership33.6%
Management average tenure2.6yrs
Board average tenure2.6yrs

Recent management updates

Recent updates

Health Check: How Prudently Does Nutex Health (NASDAQ:NUTX) Use Debt?

Jan 24
Health Check: How Prudently Does Nutex Health (NASDAQ:NUTX) Use Debt?

Nutex Health Inc. (NASDAQ:NUTX) Might Not Be As Mispriced As It Looks

Dec 25
Nutex Health Inc. (NASDAQ:NUTX) Might Not Be As Mispriced As It Looks

Nutex Health Inc. (NASDAQ:NUTX) Just Reported, And Analysts Assigned A US$2.75 Price Target

Aug 12
Nutex Health Inc. (NASDAQ:NUTX) Just Reported, And Analysts Assigned A US$2.75 Price Target

Nutex Health Inc.'s (NASDAQ:NUTX) 30% Cheaper Price Remains In Tune With Revenues

Apr 17
Nutex Health Inc.'s (NASDAQ:NUTX) 30% Cheaper Price Remains In Tune With Revenues

Nutex Health GAAP EPS of -$0.03, revenue of $58.05M

Aug 23

CEO Compensation Analysis

How has Tom Vo's remuneration changed compared to Nutex Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$41m

Jun 30 2024n/an/a

-US$38m

Mar 31 2024n/an/a

-US$41m

Dec 31 2023US$1mUS$992k

-US$46m

Sep 30 2023n/an/a

-US$29m

Jun 30 2023n/an/a

-US$436m

Mar 31 2023n/an/a

-US$451m

Dec 31 2022US$938kUS$932k

-US$425m

Sep 30 2022n/an/a

-US$396m

Jun 30 2022n/an/a

US$70m

Mar 31 2022n/an/a

US$122m

Dec 31 2021US$258kUS$251k

US$133m

Sep 30 2021n/an/a

US$159m

Dec 31 2020US$159kUS$151k

US$106m

Compensation vs Market: Tom's total compensation ($USD1.01M) is below average for companies of similar size in the US market ($USD1.46M).

Compensation vs Earnings: Tom's compensation has increased whilst the company is unprofitable.


CEO

Tom Vo (51 yo)

2.6yrs

Tenure

US$1,005,711

Compensation

Dr. Thomas T. Vo, M.D., MBA, also known as Tom, is Chairman of the Board and CEO of Nutex Health, Inc. from April 1, 2022. Dr. Vo joined the Nutex Health, Inc. in April 1, 2022. Thomas T. Vo, MD. has since...


Leadership Team

NamePositionTenureCompensationOwnership
Thomas Vo
Chairman of the Board & CEO2.6yrsUS$1.01m33.64%
$ 52.6m
Warren Hosseinion
President & Director2.6yrsUS$734.39k0.013%
$ 20.7k
Jon Bates
Chief Financial Officer2.4yrsUS$453.71k0.042%
$ 65.5k
Joshua DeTillio
Chief Operating Officer1.2yrsno data0.088%
$ 138.4k
LaChoenda Rosales
Director of Accountingno datano datano data
LaTanya Brackens
Director of Compliance1.3yrsno datano data
Vivian Sanders
Director of Marketingno datano datano data
Sarah Wallace
Director of Human Resources2.8yrsno datano data
Michael Chang
Chief Medical Officer2.6yrsno data1.47%
$ 2.3m
Pamela Montgomery
Chief Legal Officer of Healthcare & Board Secretaryno dataUS$275.36k0.0055%
$ 8.6k
Elisa Luqman
Chief Legal Officer of SEC & Board Secretary2.6yrsUS$593.32k0.0016%
$ 2.5k
Mark Milliner
Controllerno datano datano data

2.6yrs

Average Tenure

53yo

Average Age

Experienced Management: NUTX's management team is considered experienced (2.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Thomas Vo
Chairman of the Board & CEO2.6yrsUS$1.01m33.64%
$ 52.6m
Warren Hosseinion
President & Director2.6yrsUS$734.39k0.013%
$ 20.7k
Scott Saunders
Independent Directorless than a yearno datano data
Mitchell Creem
Independent Director2.6yrsUS$144.38k0.010%
$ 15.7k
Michael Reed
Independent Director2.6yrsUS$144.38kno data
Cheryl Grenas
Independent Director2.6yrsUS$131.25k0.0012%
$ 1.9k
Kelvin Spears
Directorless than a yearno data0.59%
$ 917.6k

2.6yrs

Average Tenure

63yo

Average Age

Experienced Board: NUTX's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.